Blumea balsamifera (L.) DC. Elicit Anti-Kinase, Anti-Phosphatase and Cytotoxic Activities against Acute Promyelocytic Leukemia Cells (HL-60)
doi.org/10.26538/tjnpr/v5i4.11
Keywords:
Blumea balsamifera, Anti-kinase, Antiphosphatase, Acute promyelocytic leukemiaAbstract
Blumea balsamfera (L.) DC. (B. balsamfera) extract has been shown to exhibit many biological activities. However, the anti-kinase, anti-phosphatase and cytotoxic activities of B. balsamfera are not well understood. Therefore, this study aimed to investigate the anti-kinase and anti-phosphatase activities using MKK1, MSG5 and PP1 screening systems. Cytotoxic activity was evaluated using acute promyelocytic leukemia cell lines (HL-60). Methanol extracts of B. balsamfera were partitioned into hexane (HE), chloroform (CE), chloroform-methanol (CME), butanol (BE) and aqueous fractions (AQE). Only the CE fraction demonstrated toxic activity against PP1 screening system. Other fractions did not show activity in PP1 screening. CE fractions were further fractionated using silica gel chromatography and a further 11 fractions were obtained. Fraction 2 (CE.F2) showed activity against PP1 and was further fractionated and tested. CE.F2.F6.F3 fraction tested positive against PP1. Inhibition of PP1 by the F2.F6.F3 fraction was further confirmed using an enzymatic reaction and the Vmax and Km constants were 124.999 µmol/ml.min and 204.624 µM, respectively. A Lineweaver-Burk plot outcome of F2.F6.F3 revealed decreasing of Km and Vmax values which supported the inhibition of PP1 activities. Cytotoxic activities against HL-60 were observed for the CE, CE.F1, CE.F2 and CE.F7 fractions. We have demonstrated that B. balsamfera and its specific fractions exhibited anti-kinase and anti-phosphatase activities. These substances have the potential to be used as treatment agent for acute promyelocytic leukemia.
References
Ahmad FF and Ismail G. Medicinal plants used by Kadazandusun communities around crocker range. ASEAN Review of Biodivers and Env Conservation. 2003; 1:1-10.
Ruangrungsi N, Tantivatana P, Tappayuthpijarn P, Borris RP, Cordell GA. Traditional medicinal plants of thailand vi. Isolation of cryptomeridiol from blumea balsamifera. Sci Asia. 1985; 11(1):047.
Fujimoto Y, Soemartono A, Sumatra M. Sesquiterpenelactones from Blumea balsamifera. Phytochem. 1988; 27(4):1109-1111.
Ali DMH, Wong KC, Lim PK. Flavonoids from Blumea balsamifera. Fitoter. 2015; 76(1):128-130.
Bhuiyan MNI, Chowdhury JU, Begum J. Chemical components in volatile oil from Blumea Balsmifera (L.) DC. Bangl J Bot.2009; 38:107-109.
Saewan N, Koysomboon S, Chantrapromma K. Anti-tyrosine and anti-cancer activities of flavonoids from Blumea balsamifera DC. J Med Plant Res. 2011; 5:1018-1025.
Guan K-L. The mitogen activated protein kinase signal transduction pathway: From the cell surface to the nucleus. Cellular Signal. 1994; 6(6):581-589.
Shenolikar S. Protein Serine/Threonine Phosphatases—New Avenues for Cell Regulation. Ann Rev Cell Biol. 1994; 10(1):55-86.
Zhou B, Wang Z-X, Zhao Y, Brautigan DL, Zhang Z-Y. The Specificity of Extracellular Signal-regulated Kinase 2 Dephosphorylation by Protein Phosphatases. J Biol Chem. 2002; 277(35):31818-31825.
Krauss G. Biochemistry of Signal Transduction and Regulation. (3rd Ed.). Weinheim: Wiley-VCH; 2003.
Hunter T. Protein kinases and phosphatases: The Yin and Yangof protein phosphorylation and signaling. Cell. 1995; 80(2):225-236.
Keyse SM. Protein phosphatases and the regulation of mitogenactivated protein kinase signalling. Curr Opin Cell Biol. 2000; 12(2):186-192.
Sever R and Brugge JS. Signal Transduction in Cancer. Cold Spring Harb Perspect Med. 2015; 5(4):a006098.
Peng A and Maller JL. Serine/threonine phosphatases in the DNA damage response and cancer. Oncogene 2010; 29(45):5977-5988.
Bermudez O, Pagès G, Gimond C. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am J Physiol Cell Physiol. 2010; 299(2):C189-C202.
Huang D, Ding Y, Luo W-M, Bender S, Qian C-N, Kort E, Zhang Z-F, VandenBeldt K, Duesbery NS, Resau JH, Teh BT. Inhibition of MAPK Kinase Signaling Pathways Suppressed Renal Cell Carcinoma Growth and Angiogenesis In vivo. Cancer Res. 2008; 68(1):81-88.
Wang Z, Xu J, Zhou J-Y, Liu Y, Wu GS. Mitogen-Activated Protein Kinase Phosphatase-1 Is Required for Cisplatin Resistance. Cancer Res. 2006; 66(17):8870-8877.
Wang J, Zhou J-Y, Wu GS. ERK-Dependent MKP-1 Mediated Cisplatin Resistance in Human Ovarian Cancer Cells. Cancer Res. 2007; 67(24):11933-11941.
Collins S. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987; 70(5):1233-1244.
Uzunoglu S, Uslu R, Tobu M, Saydam G, Terzioglu E, Buyukkececi F, Bedii Omay S. Augmentation of
methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors. Leukemia Res. 1999; 23(5):507-512.
Pae H-O, Seo W-G, Kim N-Y, Oh G-S, Kim G-E, Kim Y-H, Kwak H-J, Yun Y-G, Jun C-D, Chung H-T. Induction of
granulocytic differentiation in acute promyelocytic leukema cells (HL-60) by water-soluble chitosan oligomer. Leukemia Res. 2001; 25(4):339-346.
Luo L-Y, Huang J, Gou B-D, Zhang T-L, Wang K. Induction of human promyelocytic leukemia HL-60 cell differentiation into monocytes by arsenic sulphide: Involvement of serine/threonine protein phosphatases. Leukemia Res. 2006; 30(11):1399-1405.
Harborne JB. Phytochemical Methods. Springer Netherlands. 1984.
Watanabe Y, Irie K, Matsumoto K. Yeast RLM1 encodes a serum response factor-like protein that may function downstream of the Mpk1 (Slt2) mitogen-activated protein kinase pathway. Mol Cell Biol. 1995; 15(10):5740-5749.
Ho CC. Molecular Cell Biology, Biodiversity and Biotechnology. (1st ed.). Percetakan CCS Sdn Bhd, Malaysia. 2003. 9-39 p.
Andrews PD and Stark MJR. Type 1 protein phosphatase is required for maintenance of cell wall integrity, morphogenesis and cell cycle progression in Saccharomyces cerevisiae. J Cell Sci. 2000; 113:507-520.
Doi K, Gartner A, Ammerer G, Errede B, Shinkawa H, Sugimoto K, Matsumoto K. Msg5, a novel protein phosphatase promotes adaptation to pheromone in S. cerevisiae. EMBO J. 1994; 16:61-70.
Sassoon I, Severin FF, Andrews PD, Taba M-R, Kaplan KB, Ashford AJ, Stark MJR, Sorger PK, Hyman AA. Regulation of Saccharomyces cerevisiae kinetochores by the type 1 phosphatase Glc7p. Gen Dev. 1999; 13(5):545-555.
Montalibet J, Skorey K, Kennedy B. Protein tyrosine phosphatase: enzymatic assays. Methods 2005; 35(1):2-8.
Yoshino M. A graphical method for determining inhibition parameters for partial and complete inhibitors. Biochem J. 1987; 248(3):815-820.
Pezzuto JM. Natural Compounds in Cancer Therapy. John Boik, Oregon Medical Press, Princeton, MN. Pharm Biol. 2002; 40(1):79.
Hasegawa H. Dihydroflavonol BB-1, an extract of natural plant Blumea balsamifera, abrogates TRAIL resistance in leukemia cells. Blood 2006; 107(2):679-688.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
